BA
ALXN

Bristlecone Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bristlecone Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-250
Closed -$35K – 273
2017
Q3 		$35K Buy
+250
New +$35K 0.01% 215